{"id":"https://openalex.org/W2140923325","doi":"https://doi.org/10.1016/s0009-9236(98)90155-2","title":"Cognitive performance in elderly subjects after a single dose of befloxatone, a new reversible selective monoamine oxidase A inhibitor*","display_name":"Cognitive performance in elderly subjects after a single dose of befloxatone, a new reversible selective monoamine oxidase A inhibitor*","publication_year":1998,"publication_date":"1998-08-01","ids":{"openalex":"https://openalex.org/W2140923325","doi":"https://doi.org/10.1016/s0009-9236(98)90155-2","mag":"2140923325","pmid":"https://pubmed.ncbi.nlm.nih.gov/9728902"},"language":"en","primary_location":{"id":"doi:10.1016/s0009-9236(98)90155-2","doi":"https://doi.org/10.1016/s0009-9236(98)90155-2","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0009-9236(98)90155-2","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112828156","display_name":"Pierre Rosenzweig","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267926","display_name":"Biotrial (France)","ror":"https://ror.org/052kfss93","country_code":"FR","type":"company","lineage":["https://openalex.org/I4405267926"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Pierre Rosenzweig","raw_affiliation_strings":["Synth\u00e9labo Recherche, Clinical Development Department, Bagneux, France","Biotrial SA, Technopole Atalante Villejean, Rennes, France","Synthe\u0301labo Recherche, Clinical Development Department, Bagneux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synth\u00e9labo Recherche, Clinical Development Department, Bagneux, France","institution_ids":[]},{"raw_affiliation_string":"Biotrial SA, Technopole Atalante Villejean, Rennes, France","institution_ids":["https://openalex.org/I4405267926"]},{"raw_affiliation_string":"Synthe\u0301labo Recherche, Clinical Development Department, Bagneux, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051365872","display_name":"Alain A. Patat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267926","display_name":"Biotrial (France)","ror":"https://ror.org/052kfss93","country_code":"FR","type":"company","lineage":["https://openalex.org/I4405267926"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Alain Patat","raw_affiliation_strings":["Biotrial SA, Technopole Atalante Villejean, Rennes, France","Synthe\u0301labo Recherche, Clinical Development Department, Bagneux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biotrial SA, Technopole Atalante Villejean, Rennes, France","institution_ids":["https://openalex.org/I4405267926"]},{"raw_affiliation_string":"Synthe\u0301labo Recherche, Clinical Development Department, Bagneux, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017092902","display_name":"Isabelle Zieleniuk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267926","display_name":"Biotrial (France)","ror":"https://ror.org/052kfss93","country_code":"FR","type":"company","lineage":["https://openalex.org/I4405267926"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Isabelle Zieleniuk","raw_affiliation_strings":["Biotrial SA, Technopole Atalante Villejean, Rennes, France","Synthe\u0301labo Recherche, Clinical Development Department, Bagneux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biotrial SA, Technopole Atalante Villejean, Rennes, France","institution_ids":["https://openalex.org/I4405267926"]},{"raw_affiliation_string":"Synthe\u0301labo Recherche, Clinical Development Department, Bagneux, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033199435","display_name":"Isabelle Cimarosti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267926","display_name":"Biotrial (France)","ror":"https://ror.org/052kfss93","country_code":"FR","type":"company","lineage":["https://openalex.org/I4405267926"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Isabelle Cimarosti","raw_affiliation_strings":["Biotrial SA, Technopole Atalante Villejean, Rennes, France","Synthe\u0301labo Recherche, Clinical Development Department, Bagneux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biotrial SA, Technopole Atalante Villejean, Rennes, France","institution_ids":["https://openalex.org/I4405267926"]},{"raw_affiliation_string":"Synthe\u0301labo Recherche, Clinical Development Department, Bagneux, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111604645","display_name":"H. Allain","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267926","display_name":"Biotrial (France)","ror":"https://ror.org/052kfss93","country_code":"FR","type":"company","lineage":["https://openalex.org/I4405267926"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Herv\u00e9 Allain","raw_affiliation_strings":["Biotrial SA, Technopole Atalante Villejean, Rennes, France","Synthe\u0301labo Recherche, Clinical Development Department, Bagneux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biotrial SA, Technopole Atalante Villejean, Rennes, France","institution_ids":["https://openalex.org/I4405267926"]},{"raw_affiliation_string":"Synthe\u0301labo Recherche, Clinical Development Department, Bagneux, France","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108416771","display_name":"Jean\u2010Marc Gandon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267926","display_name":"Biotrial (France)","ror":"https://ror.org/052kfss93","country_code":"FR","type":"company","lineage":["https://openalex.org/I4405267926"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Marc Gandon","raw_affiliation_strings":["Biotrial SA, Technopole Atalante Villejean, Rennes, France","Synthe\u0301labo Recherche, Clinical Development Department, Bagneux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biotrial SA, Technopole Atalante Villejean, Rennes, France","institution_ids":["https://openalex.org/I4405267926"]},{"raw_affiliation_string":"Synthe\u0301labo Recherche, Clinical Development Department, Bagneux, France","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5112828156"],"corresponding_institution_ids":["https://openalex.org/I4405267926"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":0.2118,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.51759729,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"64","issue":"2","first_page":"211","last_page":"222"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/monoamine-oxidase-a-inhibitors","display_name":"monoamine oxidase A inhibitors","score":0.8539999723434448},{"id":"https://openalex.org/keywords/amitriptyline","display_name":"amitriptyline","score":0.8830000162124634},{"id":"https://openalex.org/keywords/cognitive-performance","display_name":"cognitive performance","score":0.7279999852180481},{"id":"https://openalex.org/keywords/psychomotor-function","display_name":"psychomotor performance","score":0.9929999709129333},{"id":"https://openalex.org/keywords/memory","display_name":"memory","score":0.6620000004768372},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.8270000219345093},{"id":"https://openalex.org/keywords/antidepressant-side-effects","display_name":"antidepressant side effects","score":0.7409999966621399},{"id":"https://openalex.org/keywords/alertness","display_name":"alertness","score":0.8109999895095825},{"id":"https://openalex.org/keywords/sleep","display_name":"sleep","score":0.6069999933242798},{"id":"https://openalex.org/keywords/tricyclic-antidepressants","display_name":"tricyclic antidepressants","score":0.8119999766349792}],"concepts":[{"id":"https://openalex.org/C200678441","wikidata":"https://www.wikidata.org/wiki/Q1423044","display_name":"Alertness","level":2,"score":0.6869720816612244},{"id":"https://openalex.org/C2777965283","wikidata":"https://www.wikidata.org/wiki/Q5275755","display_name":"Digit symbol substitution test","level":4,"score":0.6699140071868896},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5918303728103638},{"id":"https://openalex.org/C164953862","wikidata":"https://www.wikidata.org/wiki/Q7256440","display_name":"Psychomotor learning","level":3,"score":0.5816846489906311},{"id":"https://openalex.org/C185711340","wikidata":"https://www.wikidata.org/wiki/Q5347381","display_name":"Effects of sleep deprivation on cognitive performance","level":3,"score":0.5219547152519226},{"id":"https://openalex.org/C548259974","wikidata":"https://www.wikidata.org/wiki/Q569965","display_name":"Audiology","level":1,"score":0.49231255054473877},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.48139333724975586},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.46716225147247314},{"id":"https://openalex.org/C2778689640","wikidata":"https://www.wikidata.org/wiki/Q113259","display_name":"Anticholinergic","level":2,"score":0.4655592739582062},{"id":"https://openalex.org/C2780216858","wikidata":"https://www.wikidata.org/wiki/Q58397","display_name":"Amitriptyline","level":2,"score":0.45607924461364746},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.4408869743347168},{"id":"https://openalex.org/C152484397","wikidata":"https://www.wikidata.org/wiki/Q186129","display_name":"Flicker fusion threshold","level":3,"score":0.41425585746765137},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3923925459384918},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.3526405692100525},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32640165090560913},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2837488353252411},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C19743564","wikidata":"https://www.wikidata.org/wiki/Q25378119","display_name":"Flicker","level":2,"score":0.0},{"id":"https://openalex.org/C119599485","wikidata":"https://www.wikidata.org/wiki/Q43035","display_name":"Electrical engineering","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000639","descriptor_name":"Amitriptyline","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008996","descriptor_name":"Monoamine Oxidase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010080","descriptor_name":"Oxazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011597","descriptor_name":"Psychomotor Performance","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D012016","descriptor_name":"Reference Values","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0009-9236(98)90155-2","doi":"https://doi.org/10.1016/s0009-9236(98)90155-2","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0009-9236(98)90155-2","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmid:9728902","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9728902","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W36670681","https://openalex.org/W374385663","https://openalex.org/W1965234746","https://openalex.org/W1967958681","https://openalex.org/W1971813937","https://openalex.org/W1974963987","https://openalex.org/W1983565182","https://openalex.org/W1987304702","https://openalex.org/W1989252018","https://openalex.org/W1989532375","https://openalex.org/W1994657866","https://openalex.org/W1996933156","https://openalex.org/W1998146622","https://openalex.org/W1998815930","https://openalex.org/W2003059806","https://openalex.org/W2014885375","https://openalex.org/W2015283534","https://openalex.org/W2016274094","https://openalex.org/W2020336297","https://openalex.org/W2021068001","https://openalex.org/W2028912602","https://openalex.org/W2033150979","https://openalex.org/W2037911192","https://openalex.org/W2040145802","https://openalex.org/W2046524237","https://openalex.org/W2052699219","https://openalex.org/W2054377010","https://openalex.org/W2054424962","https://openalex.org/W2056559751","https://openalex.org/W2059053760","https://openalex.org/W2060811322","https://openalex.org/W2064513638","https://openalex.org/W2075834218","https://openalex.org/W2077359421","https://openalex.org/W2078176567","https://openalex.org/W2080911984","https://openalex.org/W2084978156","https://openalex.org/W2096266931","https://openalex.org/W2119870947","https://openalex.org/W2143017058","https://openalex.org/W2434307473","https://openalex.org/W3011415551","https://openalex.org/W3035877465","https://openalex.org/W4253210359"],"related_works":["https://openalex.org/W2033150979","https://openalex.org/W1967958681","https://openalex.org/W1918320854","https://openalex.org/W4298530503","https://openalex.org/W2164738640","https://openalex.org/W1991557633","https://openalex.org/W1992004606","https://openalex.org/W2078176567","https://openalex.org/W2036411184","https://openalex.org/W1965911022"],"abstract_inverted_index":{"BACKGROUND:":[0],"Patients":[1],"with":[2,53],"depression":[3],"often":[4],"have":[5],"cognitive":[6,44],"and":[7,19,58,75,86,132,138,175,178,183,214,221,267],"psychomotor":[8,76,128,197,268],"performance":[9,77,166,198,269],"impairments.":[10],"Antidepressive":[11],"treatments":[12],"can":[13],"correct":[14],"these":[15],"deficits,":[16],"provided":[17],"sedative":[18],"anticholinergic":[20],"adverse":[21],"effects":[22,42,72,164,252],"do":[23],"not":[24,193,223],"add":[25],"to":[26,106,247],"the":[27,63,113,161,203,240,261],"preexisting":[28],"condition,":[29],"particularly":[30],"in":[31,92,101,156,243,255,270],"elderly":[32,104,256,271],"patients.":[33],"Newly":[34],"developed":[35],"antidepressants":[36],"therefore":[37],"should":[38],"be":[39],"without":[40],"deleterious":[41,163,251],"on":[43,62,73,136,142,165,265],"functions,":[45],"including":[46],"memory.":[47,133],"Befloxatone":[48],"is":[49],"a":[50,54,93,118,231],"new":[51],"antidepressant":[52],"potent,":[55],"selective,":[56],"competitive,":[57],"reversible":[59],"inhibitory":[60],"activity":[61],"A":[64],"isoform":[65],"of":[66,78,82,112,121,153,187,212,234,263],"monoamine":[67],"oxidase":[68],"(MAO-A).":[69],"METHODS:":[70],"The":[71,110],"cognition":[74,195,266],"single":[79,232],"oral":[80],"doses":[81],"befloxatone":[83,191,217,237,264],"(10":[84],"mg)":[85,89],"amitriptyline":[87],"(50":[88],"were":[90,115,140],"compared":[91],"randomized,":[94],"double-blind,":[95],"placebo-controlled,":[96],"three-way":[97],"crossover":[98],"design":[99],"trial":[100],"12":[102],"healthy":[103],"(65":[105],"85":[107],"years)":[108],"volunteers.":[109],"performances":[111],"subjects":[114],"evaluated":[116],"by":[117,150],"comprehensive":[119],"battery":[120],"validated":[122],"psychometric":[123],"tests":[124],"that":[125],"explored":[126],"alertness,":[127],"performance,":[129],"information":[130],"processing,":[131],"Subjective":[134],"feelings":[135,211,227],"mood":[137],"sleep":[139],"rated":[141],"visual":[143],"analog":[144],"scales.":[145],"MAO-A":[146],"inhibition":[147],"was":[148],"estimated":[149],"multiple":[151],"titrations":[152],"3,4-dihydrophenylglycol":[154],"(DHPG)":[155],"plasma.":[157,244],"RESULTS:":[158],"Amitriptyline":[159,207],"displayed":[160],"expected":[162],"tasks,":[167],"critical":[168],"flicker":[169],"fusion":[170],"threshold,":[171],"digit":[172],"symbol":[173],"substitution,":[174],"body":[176],"sway,":[177],"it":[179],"deteriorated":[180],"memory":[181],"(immediate":[182],"delayed":[184,204],"free":[185,205],"recall":[186],"words).":[188],"In":[189],"contrast,":[190],"did":[192,222],"impair":[194],"or":[196,228],"but":[199,216],"instead":[200],"significantly":[201],"improved":[202],"recall.":[206],"adversely":[208],"affected":[209],"subjective":[210,226],"alertness":[213,220],"contentedness,":[215],"permitted":[218],"sustained":[219],"alter":[224],"other":[225],"sleep.":[229],"Concurrently,":[230],"dose":[233],"10":[235],"mg":[236],"markedly":[238],"decreased":[239],"DHPG":[241],"concentration":[242],"CONCLUSION:":[245],"Contrary":[246],"tricyclic":[248],"antidepressants,":[249],"whose":[250],"are":[253],"greater":[254],"subjects,":[257],"this":[258],"study":[259],"demonstrated":[260],"safety":[262],"subjects.":[272]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
